• Return to Headlines

Pacira Pharmaceu Up 35.6% Since SmarTrend Uptrend Call (PCRX)

By David Diaz

SmarTrend identified an Uptrend for Pacira Pharmaceu (NASDAQ:PCRX) on July 10th, 2018 at $34.65. In approximately 2 months, Pacira Pharmaceu has returned 35.64% as of today's recent price of $47.00.

In the past 52 weeks, shares of Pacira Pharmaceu have traded between a low of $26.95 and a high of $48.40 and are now at $47.00, which is 74% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 2.0% while the 200-day MA has remained constant.

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company with focuses on the development, commercialization, and manufacturing of proprietary pharmaceutical products. The Company's products are used in hospitals and ambulatory surgery centers.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Pacira Pharmaceu shares.

Log in and add Pacira Pharmaceu (PCRX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights pacira pharmaceu

Ticker(s): PCRX